COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.
Professor Julia Hippisley-Cox and Dr Tingting Zhu win funding for their collaborative project on novel test technologies for patient triage in primary care.
The first major study to investigate dairy consumption and cancer risk in Chinese adults found that greater intake was associated with higher risks of liver cancer and female breast cancer.
The new Oxford-developed artificial intelligence tool PathProfiler automates the quality control of large retrospective pathology image datasets to increase their usability in downstream research.
Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union\u2019s Medical Device Regulation.
Professor Jason Davis has been awarded a Cancer Research UK Early Detection and Diagnosis Primer Award to develop a single-step, ultra-sensitive device for detecting breast cancer cells in the blood.
Faecal immunochemical testing (FIT) alone leads to the identification of the same number of patients with colorectal cancer as more complicated approaches that combine the FIT result with the results of commonly used blood tests.
New data from the Million Women Study indicates that adiposity at different life stages is likely to affect the risk of postmenopausal breast cancer through distinct mechanisms.
A UK-first operation that replaced the sternum of a cancer patient using the chest wall of a deceased donor has been carried out at Oxford University Hospitals NHS Foundation Trust (OUH).
Results from a large-scale analysis show that following a vegetarian or pescatarian (fish-eating) diet could significantly reduce the risk of developing cancer \u2013 but even limiting red and processed meat to five meals a week or less may also have a benefit.
The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme.
New research by Oxford researchers into sudden weight loss finds a possible cause of cachexia (sudden weight loss & muscle wasting) in cancer patients and Cockayne syndrome in children.
![\"Blood](\"https://www.cancer.ox.ac.uk/news/largest-study-to-date-confirms-role-of-two-hormones-in-aggressive-prostate-cancer-risk/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n